Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis

Takeshi Fujii, Masayuki Yoshizawa, Katsuhiko Nakai, Kazuko Fujimoto, Takeshi Suzuki, Koichiro Kawashima

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The role of the serotonin (5-HT)(1A) receptor in the regulation of acetylcholine (ACh) release in the hippocampus was investigated using an in vivo microdialysis technique and a sensitive radioimmunoassay specific for ACh. The mean (± S.E.M.) basal ACh contents in the hippocampal perfusate of conscious, freely moving rats was 60 ± 4 (n = 29) and 3691 ± 265 fmol/30 min(n = 31), respectively, in the absence and presence of physostigmine (Phy) in the perfusion fluid. Systemic administration of 8-hydroxy-2-(di-n- propylamino)tetralin (8-OH-DPAT, 0.5 mg/kg, s.c.), a 5-HT(1A) agonist, significantly enhanced ACh release both in the presence and absence of Phy. Local application of 8-OH-DPAT (3-30 μM) into the hippocampus through the microdialysis probe significantly potentiated ACh release only in the presence of Phy, whereas no significant effect was observed in its absence. Pretreatment with NAN-190 (3 mg/kg, i.p.), a 5-HT(1A) antagonist, eliminated the increasing effect of systemically applied 8-OH-DPAT on ACh release, while NAN-190 alone had no effect on basal ACh release either in the absence or presence of Phy. Consistent with the time course of ACh release, systemic administration of 8-OH-DPAT evoked hyperlocomotion, which was reversed by NAN-190. However, local hippocampal application of 8-OH-DPAT did not affect the locomotor activity of the rats. These findings suggest that at least two different sites are involved in the 8-OH-DPAT-induced increase in the release of ACh in the rat hippocampus in vivo.

Original languageEnglish
Pages (from-to)244-249
Number of pages6
JournalBrain Research
Volume761
Issue number2
DOIs
Publication statusPublished - 1997 Jul 4

Fingerprint

8-Hydroxy-2-(di-n-propylamino)tetralin
Microdialysis
Cholinergic Agents
Acetylcholine
Hippocampus
Physostigmine
hydroxide ion
Serotonin Receptor Agonists
Serotonin Antagonists
Receptor, Serotonin, 5-HT1A
Locomotion
Radioimmunoassay
Serotonin
Perfusion

Keywords

  • 8-Hydroxy-2(di-n-propylamino)tetralin
  • Acetylcholine
  • Hippocampus
  • Microdialysis
  • NAN- 190
  • Radioimmunoassay
  • Serotonin(1A) receptor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. / Fujii, Takeshi; Yoshizawa, Masayuki; Nakai, Katsuhiko; Fujimoto, Kazuko; Suzuki, Takeshi; Kawashima, Koichiro.

In: Brain Research, Vol. 761, No. 2, 04.07.1997, p. 244-249.

Research output: Contribution to journalArticle

Fujii, Takeshi ; Yoshizawa, Masayuki ; Nakai, Katsuhiko ; Fujimoto, Kazuko ; Suzuki, Takeshi ; Kawashima, Koichiro. / Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. In: Brain Research. 1997 ; Vol. 761, No. 2. pp. 244-249.
@article{4a0e88f5b5e04e52a0afb798d1b70e1f,
title = "Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis",
abstract = "The role of the serotonin (5-HT)(1A) receptor in the regulation of acetylcholine (ACh) release in the hippocampus was investigated using an in vivo microdialysis technique and a sensitive radioimmunoassay specific for ACh. The mean (± S.E.M.) basal ACh contents in the hippocampal perfusate of conscious, freely moving rats was 60 ± 4 (n = 29) and 3691 ± 265 fmol/30 min(n = 31), respectively, in the absence and presence of physostigmine (Phy) in the perfusion fluid. Systemic administration of 8-hydroxy-2-(di-n- propylamino)tetralin (8-OH-DPAT, 0.5 mg/kg, s.c.), a 5-HT(1A) agonist, significantly enhanced ACh release both in the presence and absence of Phy. Local application of 8-OH-DPAT (3-30 μM) into the hippocampus through the microdialysis probe significantly potentiated ACh release only in the presence of Phy, whereas no significant effect was observed in its absence. Pretreatment with NAN-190 (3 mg/kg, i.p.), a 5-HT(1A) antagonist, eliminated the increasing effect of systemically applied 8-OH-DPAT on ACh release, while NAN-190 alone had no effect on basal ACh release either in the absence or presence of Phy. Consistent with the time course of ACh release, systemic administration of 8-OH-DPAT evoked hyperlocomotion, which was reversed by NAN-190. However, local hippocampal application of 8-OH-DPAT did not affect the locomotor activity of the rats. These findings suggest that at least two different sites are involved in the 8-OH-DPAT-induced increase in the release of ACh in the rat hippocampus in vivo.",
keywords = "8-Hydroxy-2(di-n-propylamino)tetralin, Acetylcholine, Hippocampus, Microdialysis, NAN- 190, Radioimmunoassay, Serotonin(1A) receptor",
author = "Takeshi Fujii and Masayuki Yoshizawa and Katsuhiko Nakai and Kazuko Fujimoto and Takeshi Suzuki and Koichiro Kawashima",
year = "1997",
month = "7",
day = "4",
doi = "10.1016/S0006-8993(97)00325-9",
language = "English",
volume = "761",
pages = "244--249",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis

AU - Fujii, Takeshi

AU - Yoshizawa, Masayuki

AU - Nakai, Katsuhiko

AU - Fujimoto, Kazuko

AU - Suzuki, Takeshi

AU - Kawashima, Koichiro

PY - 1997/7/4

Y1 - 1997/7/4

N2 - The role of the serotonin (5-HT)(1A) receptor in the regulation of acetylcholine (ACh) release in the hippocampus was investigated using an in vivo microdialysis technique and a sensitive radioimmunoassay specific for ACh. The mean (± S.E.M.) basal ACh contents in the hippocampal perfusate of conscious, freely moving rats was 60 ± 4 (n = 29) and 3691 ± 265 fmol/30 min(n = 31), respectively, in the absence and presence of physostigmine (Phy) in the perfusion fluid. Systemic administration of 8-hydroxy-2-(di-n- propylamino)tetralin (8-OH-DPAT, 0.5 mg/kg, s.c.), a 5-HT(1A) agonist, significantly enhanced ACh release both in the presence and absence of Phy. Local application of 8-OH-DPAT (3-30 μM) into the hippocampus through the microdialysis probe significantly potentiated ACh release only in the presence of Phy, whereas no significant effect was observed in its absence. Pretreatment with NAN-190 (3 mg/kg, i.p.), a 5-HT(1A) antagonist, eliminated the increasing effect of systemically applied 8-OH-DPAT on ACh release, while NAN-190 alone had no effect on basal ACh release either in the absence or presence of Phy. Consistent with the time course of ACh release, systemic administration of 8-OH-DPAT evoked hyperlocomotion, which was reversed by NAN-190. However, local hippocampal application of 8-OH-DPAT did not affect the locomotor activity of the rats. These findings suggest that at least two different sites are involved in the 8-OH-DPAT-induced increase in the release of ACh in the rat hippocampus in vivo.

AB - The role of the serotonin (5-HT)(1A) receptor in the regulation of acetylcholine (ACh) release in the hippocampus was investigated using an in vivo microdialysis technique and a sensitive radioimmunoassay specific for ACh. The mean (± S.E.M.) basal ACh contents in the hippocampal perfusate of conscious, freely moving rats was 60 ± 4 (n = 29) and 3691 ± 265 fmol/30 min(n = 31), respectively, in the absence and presence of physostigmine (Phy) in the perfusion fluid. Systemic administration of 8-hydroxy-2-(di-n- propylamino)tetralin (8-OH-DPAT, 0.5 mg/kg, s.c.), a 5-HT(1A) agonist, significantly enhanced ACh release both in the presence and absence of Phy. Local application of 8-OH-DPAT (3-30 μM) into the hippocampus through the microdialysis probe significantly potentiated ACh release only in the presence of Phy, whereas no significant effect was observed in its absence. Pretreatment with NAN-190 (3 mg/kg, i.p.), a 5-HT(1A) antagonist, eliminated the increasing effect of systemically applied 8-OH-DPAT on ACh release, while NAN-190 alone had no effect on basal ACh release either in the absence or presence of Phy. Consistent with the time course of ACh release, systemic administration of 8-OH-DPAT evoked hyperlocomotion, which was reversed by NAN-190. However, local hippocampal application of 8-OH-DPAT did not affect the locomotor activity of the rats. These findings suggest that at least two different sites are involved in the 8-OH-DPAT-induced increase in the release of ACh in the rat hippocampus in vivo.

KW - 8-Hydroxy-2(di-n-propylamino)tetralin

KW - Acetylcholine

KW - Hippocampus

KW - Microdialysis

KW - NAN- 190

KW - Radioimmunoassay

KW - Serotonin(1A) receptor

UR - http://www.scopus.com/inward/record.url?scp=0030790860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030790860&partnerID=8YFLogxK

U2 - 10.1016/S0006-8993(97)00325-9

DO - 10.1016/S0006-8993(97)00325-9

M3 - Article

VL - 761

SP - 244

EP - 249

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -